海外の感染症の最新の流行状況を情報をお知らせいたします。
※出典が海外のため原文のまま掲載しています。最新の記事はこちら
2026年3月3日時点の情報
Mpox: recombinant virus with genomic elements of clades Ib and IIb|14 February 2026|Global
Case detected in the United Kingdom of Great Britain and Northern Ireland
Epidemiological Update Dengue in the Americas Region – 18 February 2026|18 Feb 2026 |Pan American Health Organization
The Pan American Health Organization/World Health Organization (PAHO/WHO) is issuing this Epidemiological Update to summarize the dengue situation in the Region and remind Member States of the need to maintain and strengthen prevention and surveillance actions. It also urges them to remain alert to increases in cases so that they can organize and adapt health services in a timely manner to ensure prompt, high-quality clinical management, prevent complications, and avoid overwhelming specialized care services. In addition, PAHO/WHO recommends strengthening and deploying integrated vector management actions in areas of highest risk, including health facilities that care for patients with dengue.
WHO convenes global experts in Brazzaville to strengthen clinical care for filovirus…|23 February 2026|African Region
As outbreaks of Filovirus Disease (FVD) continue to regularly affect countries across Africa and in efforts to increase preparedness capacities, the World Health Organization (WHO) with support from the Foreign, Commonwealth and Development Office has convened 50 clinicians, researchers and public health specialists globally and partners for a five-day Filovirus Disease Optimized Supportive Care Workshop to update and harmonize clinical management guidelines.
Source:https://www.afro.who.int/news/who-convenes-global-experts-brazzaville-strengthen-clinical-care-filovirus-diseases
River blindness or onchocerciasis : How to fight a parasite that threatens eyesight|26 February 2026|African Region
Onchocerciasis, also known as “river blindness,” still affects millions of people living near rivers and wetlands in Africa. Fortunately, this disease can be prevented through a simple, free treatment that is distributed annually within communities.
Epidemiological Alert: Misuse of GLP-1 receptor agonist medications and considerations for the Americas Region – 27 February 2026|27 Feb 2026 |Pan American Health Organization
In recent months, there has been an increase in the number of countries reporting adverse effects of varying severity associated with the misuse of glucagon-like peptide-1 (GLP-1) receptor agonists indicated for the treatment of obesity in adults. In this context, the Pan American Health Organization/World Health Organization (PAHO/WHO) urges Member States to strengthen pharmacovigilance systems, promote timely reporting of adverse events, and implement risk communication actions aimed at both the general population—to promote the proper use of these drugs—and health personnel, to ensure that they are prescribed strictly in accordance with the indications approved by national regulatory authorities, based on an individual clinical assessment and with continuous medical monitoring.
Onchocerciasis: How to fight a parasite that threatens eyesight|26 February 2026|African Region
Onchocerciasis, also known as river blindness, still affects millions of people living near rivers and wetlands in Africa. Fortunately, this disease can be prevented through a simple, free treatment that is distributed annually within communities. To better understand it’s transmission, who is most exposed, and what progress has been made, we spoke with Dr Didier Bakajika, expert at WHO Africa.What is river blindness and how is it transmitted?